People channel feed

Eiger Bio­Phar­ma­ceu­ti­cals to fo­cus on GLP-1 can­di­date, cut work­force by 25%

Last year
R&D

ICER taps new pres­i­dent as Steve Pear­son an­nounces plans to step down

Last year
Pharma

Over­board: Alex­is Borisy will have to lim­it di­rec­tor posts to stay on at Blue­print

Last year

Gene ther­a­py biotech Cap­si­da lays off work­ers af­ter ex­pand­ing Ab­b­Vie pact, adding Lil­ly col­lab

Last year
Startups
Cell/Gene Tx

Emer­gent BioSo­lu­tions CEO Robert Kramer an­nounces re­tire­ment

Last year
Manufacturing

Il­lu­mi­na lays off work­ers and cuts of­fice foot­print as part of cost-re­duc­tion mea­sures

Last year

Af­ter steer­ing Lund­beck through buy­outs, lay­offs and big ap­proval, Deb­o­rah Dun­sire will step down

Last year

Biotech ex­ecs urge in­dus­try to sup­port ac­cess to gen­der-af­firm­ing care, as­sist work­ers amid rush of an­ti-LGBTQ bills

Last year

Bio­gen share­hold­ers elect biotech ex­ec Su­san Langer to the board af­ter ro­man­tic part­ner de­parts

Last year

Ra­dioiso­tope man­u­fac­tur­er North­Star Med­ical Tech­nolo­gies names new CEO

Last year
Manufacturing

Saris­sa's Alk­er­mes board re­place­ments large­ly fail to win sup­port from share­hold­er firms, which cite Bio­gen board moves

Last year

Catal­ent names new CFO as con­tract man­u­fac­tur­er's ef­fort to right its op­er­a­tions con­tin­ues

Last year
Manufacturing

Q&A with Genen­tech CEO Alexan­der Hardy on Medicare's drug price ne­go­ti­a­tions

Last year
Law

Co­herus to buy Sur­face On­col­o­gy in stock deal val­ued at $65M

Last year
Deals

Astel­las CEO Nao­ki Oka­mu­ra says part­ner­ships 'crit­i­cal' to growth plans

Last year
Pharma

Am­gen taps Mod­er­na vet Paul Bur­ton as new CMO

Last year
Pharma

En­cod­ed Ther­a­peu­tics, a well-fund­ed CNS gene ther­a­py mak­er, lays off 10% of staff 

Last year
Startups
Cell/Gene Tx

Saris­sa goes af­ter Alk­er­mes, seek­ing three board seats at the Irish drug­mak­er

Last year

Ery­tech blasts ac­tivist in­vestor's at­tempt to block re­verse merg­er, Akka­di­an pro­pos­es new board in re­turn

Last year
Deals

Bio­gen board re­place­ment for Alex Den­ner, Su­san Langer, is said to be the in­vestor’s ro­man­tic part­ner

Last year

Alex Den­ner is out at Bio­gen as new CEO Viehbach­er crafts a fresh board with Su­san Langer, Car­o­line Dor­sa

Last year

Xalud Ther­a­peu­tics pri­or­i­tizes gene ther­a­pies, with ALS now the fo­cus and os­teoarthri­tis on part­ner path 

Last year
Startups
Cell/Gene Tx

Re­ju­ve­nate Bio shrinks staff, pipeline fo­cus as George Church spin­out eyes 2024 gene ther­a­py IND

Last year
Startups
Cell/Gene Tx

Ex­clu­sive: Il­lu­mi­na CEO Fran­cis deS­ouza re­signs, fol­low­ing chal­lenge by ac­tivist in­vestor

Last year
First page Previous page 24252627282930 Next page Last page
A service from the Financial Times